Edgewise Therapeutics Inc (EWTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 46,858 | 42,610 | 45,959 | 45,540 | 40,432 |
| Operating Income | -46,858 | -42,610 | -45,959 | -45,540 | -40,432 |
| Other Income | 6,192 | 6,495 | 5,161 | 5,878 | 6,303 |
| Pre-tax Income | -40,666 | -36,115 | -40,798 | -39,662 | -34,129 |
| Net Income Continuous | -40,666 | -36,115 | -40,798 | -39,662 | -34,129 |
| Net Income | $-40,666 | $-36,115 | $-40,798 | $-39,662 | $-34,129 |
| EPS Basic Total Ops | -0.39 | -0.34 | -0.43 | -0.42 | -0.36 |
| EPS Basic Continuous Ops | -0.39 | -0.34 | -0.43 | -0.42 | -0.36 |
| EPS Diluted Total Ops | -0.39 | -0.34 | -0.43 | -0.42 | -0.36 |
| EPS Diluted Continuous Ops | -0.39 | -0.34 | -0.43 | -0.42 | -0.36 |
| EPS Diluted Before Non-Recurring Items | -0.39 | -0.34 | -0.43 | -0.42 | -0.36 |
| EBITDA(a) | $-48,344 | $-44,246 | $-47,328 | $-47,513 | $-43,070 |